Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Neurology and Neurosurgery
  • Neurology & Neurosurgery Guidelines
  • Pharmacologic...

Pharmacologic Treatment for Pediatric Migraine Prevention: Practice Guideline Update

Dr. Kamal Kant KohliWritten by Dr. Kamal Kant Kohli Published On 2023-02-27T10:00:14+05:30  |  Updated On 27 Feb 2023 7:18 AM GMT
Pharmacologic Treatment for Pediatric Migraine Prevention: Practice Guideline Update

Individuals with a family history of migraine are at higher risk of developing migraine, and female sex is a risk factor of migraine that persists into adulthood.1 Disease prevention is the cornerstone of medical care. Migraine has multiple behavioral factors that influence headache frequency. Recurrent headache in adolescents is associated with being overweight, caffeine and alcohol use, lack...

Individuals with a family history of migraine are at higher risk of developing migraine, and female sex is a risk factor of migraine that persists into adulthood.1 Disease prevention is the cornerstone of medical care. Migraine has multiple behavioral factors that influence headache frequency. Recurrent headache in adolescents is associated with being overweight, caffeine and alcohol use, lack of physical activity, poor sleep habits, and tobacco exposure.2 Depression is associated with higher headache disability in adolescents.

American Academy of Neurology (AAN ) and American Headache Society (AHS) Practice Guideline Update: Pharmacologic Treatment for Pediatric Migraine Prevention in August, 2019 Reaffirmed October 22, 2022. Replaces "Pharmacological Treatment of Migraine Headache in Children and Adolescents" (December 2004). Endorsed by the American Academy of Pediatrics and the Child Neurology Society.

Following are its major recommendations:

Counseling and Education for Children and Adolescents with Migraine and Their Families

1. Clinicians should counsel patients and families that lifestyle and behavioral factors influence headache frequency. (Level B)

2. Clinicians should educate patients and families to identify and modify migraine contributors that are potentially modifiable. (Level B)

3. Clinicians should discuss the potential role of preventive treatments in children and adolescents with frequent headache or migraine-related disability or both. (Level B)

4. Clinicians should discuss the potential role of preventive treatments in children and adolescents with medication overuse. (Level B)

Starting Preventive Treatment

5. Clinicians should inform patients and caregivers that in clinical trials of preventive treatments for pediatric migraine placebo was effective and the majority of preventive medications were not superior to placebo. (Level B)

6. Acknowledging the limitations of currently available evidence, clinicians should engage in shared decision making regarding the use of short-term treatment trials (a minimum of 2 months) for those who could benefit from preventive treatment. (Level B)

7. Clinicians should discuss the evidence for amitriptyline combined with CBT for migraine prevention, inform them of the potential side effects of amitriptyline including risk of suicide, and work with families to identify providers who can offer this type of treatment. (Level B)

8. Clinicians should discuss the evidence for topiramate for migraine prevention in children and adolescents and its side effects in this population. (Level B)

9. Clinicians should discuss the evidence for propranolol for migraine prevention and its side effects in children and adolescents. (Level B)

Counseling for Patients of Child Bearing Potential

10. Clinicians must consider the teratogenic effect of topiramate and valproate in their choice of migraine prevention therapy recommendations to patients of childbearing potential. (Level A)

11. Clinicians who offer topiramate or valproate for migraine prevention to patients of childbearing potential must counsel these patients about potential effects on fetal-childhood development. (Level A)

12. Clinicians who prescribe topiramate for migraine prevention to patients of childbearing potential must counsel these patients about the potential of this medication to decrease the efficacy of oral combined hormonal contraceptives, particularly at doses over 200 mg daily. (Level A)

13. Clinicians who prescribe topiramate or valproate for migraine prevention to patients of childbearing potential should counsel patients to discuss optimal contraception methods with their health care provider during treatment. (Level B)

14. Clinicians must recommend daily folic acid supplementation to patients of childbearing potential who take topiramate or valproate. (Level A)

Monitoring and Stopping Medication

15. Clinicians must periodically monitor medication effectiveness and adverse events when prescribing migraine preventive treatments. (Level A)

16. Clinicians should counsel patient and families about risks and benefits of stopping preventive medication once good migraine control is established. (Level B)

Mental Illness in Children and Adolescents with Migraine

17. Children and adolescents with migraine should be screened for mood and anxiety disorders because of the increased risk of headache persistence. (Level B)

18. In children and adolescents with migraine who have comorbid mood and anxiety disorders, clinicians should discuss management options for these disorders. (Level B)

Reference:

Maryam Oskoui, Tamara Pringsheim, Lori Billinghurst, Sonja Potrebic, Elaine M. Gersz, David Gloss, Yolanda Holler-Managan, Emily Leininger, Nicole Licking, Kenneth Mack, Scott W. Powers, Michael Sowell, M. Cristina Victorio, Marcy Yonker, Heather Zanitsch, Andrew D. Hershey Neurology Sep 2019, 93 (11) 500-509; DOI: 10.1212/WNL.0000000000008105

American Academy of Neurology AAN AAN guidelines migraine migraine prevention pediatric migraine 
Source : American Academy of Neurology,AAN
Dr. Kamal Kant Kohli
Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Before Joining Medical Dialogues, he has served at important positions in the medical industry in India including as the Hony. Secretary of the Delhi Medical Association as well as the chairman of Anti-Quackery Committee in Delhi and worked with other Medical Councils in India. Email: editorial@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story
    Similar Posts
    NO DATA FOUND

    Editorial

    Journal Club Today

    Health News Today

    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    X